Diversion Program Essentials:

Data Driven Solutions for Minimizing Drug Waste and Diversion Risk

This discussion of specialists from Fresenius Kabi and Protenus regarding drug diversion addresses a complex issue from multiple angles, focusing on the journey from supply chain to diversion, the pivotal role of drug waste, strategies for minimizing waste, and the broader implications of such efforts.

The dialogue underscores the complex interplay between drug waste management and diversion prevention, advocating for comprehensive strategies that address both the practical and ethical dimensions of pharmaceutical care.

Panel

Matthew Farley, PharmD, CPHIMS

Director, Medication Technology and Analytics

Fresenius Kabi

Mike Axelsen, PharmD, BCPS

Sr. Manager, Medication Technology and Analytics

Fresenius Kabi

Adam Beeler, PharmD, MS

Director, Pharmacy Services

Protenus

Register to watch

Sign up to view this expert panel video.

Fresenius Kabi is committed to protecting and respecting your privacy, and we’ll only use your personal information to administer your account and to provide the products and services you requested from us. From time to time, we would like to contact you about our products and services, as well as other content that may be of interest to you. If you consent to us contacting you for this purpose, please tick below to say how you would like us to contact you:
In order to provide you the content requested, we need to store and process your personal data. The information you provide is not shared with or sold to any third parties. If you consent to us storing your personal data for this purpose, please tick the checkbox below. We respect your privacy.

You can unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Notice.